Article info

Download PDFPDF
Potential candidate for oral pericoital contraception: evaluating ulipristal acetate plus cyclo-oxygenase-2 inhibitor for ovulation disruption

Authors

  1. Correspondence to Dr Erica P Cahill, Obstetrics and Gynecology, Stanford University, Stanford, California, USA; epcahill{at}stanford.edu
View Full Text

Citation

Cahill EP, Lerma K, Shaw KA, et al
Potential candidate for oral pericoital contraception: evaluating ulipristal acetate plus cyclo-oxygenase-2 inhibitor for ovulation disruption

Publication history

  • Received December 21, 2021
  • Accepted February 28, 2022
  • First published April 25, 2022.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.